scioDiscover - Protein Expression Analysis

Protein expression profiling with protein arrays

The scioDiscover microarray platform enables high-content, immuno-based protein profiling of diverse biological samples. It provides a comprehensive overview of proteomic changes by analyzing more than 1,400 proteins in parallel. It covers key pathways in diseases such as cancer, neurological disorders and organ failure. The technology has been successfully applied in numerous biomedical studies and in the discovery of new biomarker signatures. scioDiscover enables rapid and targeted research while providing a broad overview of potential changes at the protein level in your samples.

 

Features and Benefits

  • Covers major signaling pathways, secreted proteins, cell surface and inflammatory markers
  • more than 1,400 proteins are profiled
  • Wide range of indications covered, including oncology and organ failure
  • Robust dual-colour study design
  • Complete data analysis and study report
  • Studies in human, murine and rat samples possible*
  • Saves time, money and valuable sample

 

    Protein
 profiling
    Biomarker
 Discovery
     Target
 Discovery
     Contact
 us

 

Sample-to-Result ServiceAntibody microarray workflow

As part of our analysis service, we will not only perform the microarray experiments, but also support you with a proposal for an appropriate microarray study design and sample selection in order to optimally address your scientific question. You will receive a customized study report including statistical analysis within 3-4 weeks after receipt of your samples.

Our analysis service includes:

  • Definition of a suitable study design
  • Sample preparation
  • Protein extraction
  • Protein concentration measurements
  • Protein quality control
  • Sample labeling
  • Sample purification
  • Incubation of the samples on antibody microarrays
  • Microarray scanning
  • Raw data acquisition
  • Data normalization
  • Data analysis including cluster analysis
  • Statistical testing of differentially abundant proteins
  • Comprehensive study report

 

Analysis and Profiling of

  • Protein expression levels
  • Signaling pathways
  • Immune system activation markers
  • Transcription factors
  • Cancer pathway screening
  • Cell surface markers
  • Apoptotic processes/ apoptosis pathway
  • Disease mechanisms
  • Pathway activation in stem cells 
  • Organ damage/failure models 
  • Response of cells and tissue models to oxidative stress
  • Proteomic profiling for different cell culture conditions
  • Molecular initiate event analysis
  • Mode-of-action analysis of compounds
  • Prediction markers for toxicological effects
  • CD cell surface molecule expression in immune cells  
         

Advantages

ScioDiscover:

  • High-content protein profiling of more than 1,400 proteins 
  • Broad coverage of:
    • Signaling pathway proteins
    • Transcription factors
    • Apoptosis markers
    • Oxidative stress markers
    • Cell surface markers
    • Cytokines & chemokines
  • Minimum sample requirements
  • Native matrices (non-fractionated / non-depleted)
  • Sensitivity equal to or better than ELISA
  • Fully immuno-based assay
  • Reliable dual-color study design
  • Technical replication (4 replicates for each antibody)
  • High reproducibility (CV < 10%)

Our Team:

  • Over a decade of experience in biomedical antibody array studies
  • Reliable support from planning to the final analysis
  • Save time, money and precious sample

 

 

Which sample types can be analyzed ?

A wide range of samples can be analyzed with scioDiscover

  • Plasma or serum
  • Fresh-frozen tissue samples
  • Cellular samples
  • Cell culture supernatants
  • Cerebrospinal fluid (CSF)
  • Other sample types upon request
  • Studies can be performed on human, mouse or rat samples*

A minimal amount of sample is required, for example**

  • Plasma sample: 5µl
  • Tissue: 1mg (fresh frozen)
  • Cells: 100,000
  • CSF: 5µl

 

Reference Customers:

  • Prof. Dr. Faikah Güler, Molecular mechanisms of transplant dysfunction, Medical School Hanover, Hanover, Germany
  • Julian Kamhieh-Milz, Research Center ImmunoSciences, Charité, Berlin, Germany
  • Prof. Jose L. Peiró, Cincinnati Fetal Center Director, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, USA
 

Case studies:

Bladder Cancer

Acute Kidney Injury

 

 * Antibody array is designed to target human proteins. Due to a high sequence homology of the vast majority of proteins, it has often been successfully used to study murine, rat and ovine models as well  [Thorenz A. et al. (2018), Peiro J. et al. (2018), Reichman H. et al. (2019), Raquel F. et al. (2020)].
**Minimum quantity. These values may vary depending on the sample type, study design, storage conditions. and additional parameters.

scioPhospho: protein profiling and phosphorylation status

Our scioPhospho analysis combines protein expression profiling using scioDiscover with analysis of the corresponding protein's phosphorylation status. More than 1,400 proteins are analyzed in parallel, covering key pathways in diseases such as cancer, neurological disorders and organ failure.  This combination provides a comprehensive overview of signaling events and pathway activity regulation in your sample. scioPhosho enables targeted, rapid, and cost-effective research.

 

Key Features

  • more than 1,400 highly relevant proteins are profiled in a single assay
  • Combines analysis of phosphorylation status with protein expression level analysis
  • Analysis of tyrosine, serine, and threonine phosphorylation
  • Analysis of individual phosphorylation types is available
  • 'Sample-to-result' service
  • Comprehensive data analysis and reporting
  • Customized study report
Protein abundance levels and phosphorylation status for one individual protein out of 900 proteins tested

Advantages

  • High-content screening of proteins and phosphorylation is time and resource efficient
  • Direct comparability by analyzing the level of protein expression and the level of phosphorylation in a single assay
  • Complete analysis from a minimal amount of sample
  • Coverage of important
    • Signaling pathways
    • Transcription factors
    • Receptor molecules
    • Kinases
  • Custom data analysis options available
    • Protein interaction network analysis
    • Biological and pathway classification 
    • Lists of differentially expressed proteins and levels of phosphorylation
  • Variety of sample formats possible without the potential bias of sample fractionation or sample depletion
  • Results presented in a publication-ready format

Applications

  • T-cell activation
  • Tissue treatment response
  • Cell cycle regulation
  • Oxidative stress response
  • Cell adhesion and motility
  • Phosphorylation profiling of various signaling pathways
    • FAK phosphorylation
    • PI3K-AKT pathway
    • p53 pathway regulation
    • Alzheimer pathway regulation

Which Sample Types can be Analyzed?

A wide range of samples can be analyzed with scioPhospho

  • Fresh-frozen tissue samples
  • Cellular samples
  • Cerebrospinal fluid (CSF)
  • Plasma or serum
  • Other sample types available upon request

A minimal amount of sample is required*, for example

  • Plasma sample: 5µl
  • Tissue: 1mg (fresh-frozen)
  • Cells: 100,000
  • CSF: 5µl

 

 Our Sample-to-Result Service

As part of our analysis service, we will not only perform the microarray experiments but will also support you with an appropriate microarray study design and sample selection to best address your scientific questions. After we receive your samples, you will receive a customized study report including statistical analysis within 3-4 weeks.

Our analysis service includes:

  • Definining a suitable study design
  • Sample preparation: Protein extraction, concentration measurements, quality control, and sample purification
  • Microarray analysis
  • Raw data acquisition and data normalisation
  • Data analysis including cluster analysis
  • Statistical testing for differentially abundant proteins
  • Statistical testing for differentially phosphorylated proteins
  • Comprehensive study report

 

Contact us 

 

Case Study

Eight treated cell line samples were compared with eight control samples. Multiple proteins were identified as differentially expressed (x-axis) and/or phosphorylated (y-axis). The left graph provides an overview of the expression/phosphorylation differences for all tested proteins in the two sample groups, while the right graphs show individual protein levels. The sample status is indicated as C for control or T for treated.

 

Reference Customers

Prof. Dr. Mathias Heikenwälder, German Cancer Research Center, Heidelberg, Germany

Dr. Caroline Pabst. University Hospital Halle, Germany

 

More Information

Download our scioPhospho or scioDiscover service brochure.

Information on protein and pathway content / coverage.

Get in touch to answer any remaining questions.

Ask for a quotation to get your study started.

 

*Minimum quantity. These values may vary depending on the sample type, study design, storage conditions. and additional parameters.

 

 

scioUbi: protein profiling and ubiquitination status

Protein & ubiquitination profiling

scioUbi is a high-content protein expression and ubiquitination level analysis.
With scioUbi you can analyse more than 1,400 proteins in a single assay.

 

Features

  • Screen for differential ubiquitination status
    in more than 1,400 proteins in parallel in a single assay
  • 4 technical replicates per sample
  • Comprehensive data analysis and presentation including
    an individualised report
  • Customisation of ubiquitin detection on request

Benefits for your research

  • Two in one: High-content protein expression and ubiquitination level analysis in a single assay
  • Proteins selected for biomedical studies: Central regulators (e.g. mTor, p53), transcription factors, receptors
  • Minimal sample (e.g. tissue or cell culture samples) amounts needed for complete analysis
sciomics scioUbi Ubiquitination And Protein Profiling Biological processes selection of proteins
Biological processes
  sciomics scioUbi Ubiquitination And Protein Profiling Cell Cycle proteins coveredCell cycle: proteins in green are covered by the analysis

 

Applications

Biological effects of

  • protein degradation in health and disease
  • protein activity changes
  • protein interaction alterations
  • drug response (e.g. proteasome enhancers)

Others

  • Interplay between ubiquitination and phosphorylation (see scioPhospho)
  • Neurodegenerative diseases
  • Progression of ageing
  • Cell cycle regulation
  • Proteasome activity
  • Transcriptional regulation
  • p53 pathway regulation
  • Alzheimer pathway regulation

 

Contact us

 

scioDiscover - Drug Target Discovery

 

You have identified a compound with the desired effect ?

You are looking for its targets ?

Which additional pathways are affected ?

Which proteins are altered in a diseased tissue ?

Get a complete picture of protein expression in multiple pathways !

 

In-depth knowledge about protein expression levels is crucial for the discovery and evaluation of new drug targets. Our Scio-Discover service is fully immuno-based and covers proteins involved in key disease and signaling pathways as well as secreted proteins. Only minimal sample amounts are required for highly parallel protein analysis. There is no need for sample fractionation or depletion. Our platform is capable of processing most biological samples without extensive sample preparation, saving valuable time and resources.

 

Applications

  • Drug target identification and verification studies
  • Mechanistic studies for various indications
  • Correlation of next-gen sequencing (NGS) data with protein expression levels
  • Profile cytokine and inflammatory status of your samples

 

Key Advantages

  • Low sample consumption, for example*
    • Plasma sample: 5µl
    • Tissue: 1mg (fresh-frozen)
    • Cells: 100,000
    • CSF: 5µl
  • Investigation of human, murine and rat samples**
  • Fast turnaround time, as little as two weeks***
  • No need for laborious sample depletion or fractionation
  • High sensitivity (as sensitive as or more sensitive than ELISA)
  • High reproducibility (CV < 10%)
  • Various sample types can be analyzed
    • Blood serum or plasma
    • Tissue
    • Cell culture
    • Cerebrospinal fluid (CSF)

 

Service Features

  • Study design
  • Protein extraction and purification
  • Protein quantification
  • Protein labelling with high-performance fluorescent dyes
  • Automated array incubation and handling 
  • Array scanning and data acquisition
  • Data analysis according to your requirements
  • Customized study report

 

Overview
Scio-Discover
    Array
Content
    Biomarker
Discovery
    Contact
us

 

 

*Minimum quantity. These values may vary depending on the sample type, study design, storage conditions. and additional parameters.

** Antibody array is designed to target human proteins. Due to a high sequence homology of vast majority of proteins it was often successfully applied to study murine, rat and ovine models as well  [Thorenz A. et al. (2018), Peiro J. et al. (2018), Reichman H. et al. (2019), Raquel F. et al. (2020)].

*** Depending on study design and sample numbers.

 

scioDiscover - Protein Profiling on the Expression Level

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised range of protein profiling services available. These help you to speed up your research and generate important data at lower cost through a highly-parallel protein expression level analysis using our Scio-Discover Antibody Microarray Platform. Furthermore, you may link to and verify your Genomics and Transcriptomics data with protein expression levels.

 

Applications:

 

Key advantages:

  • High multiplexity (more than 1,400 proteins in parallel)
  • Low sample consumption
  • Investigation of human and murine samples*
  • Fast turnaround time, as low as two weeks**
  • No need for laborious depletion or fractionation of your samples
  • High sensitivity (as sensitive as an ELISA or better)
  • High reproducibility (CV < 10%)
  • Various sample types can be investigated
    • Plasma or Serum
    • fresh-frozen tissue samples
    • Cell culture samples
    • Cerebrospinal fluid (CSF)

 

Overview
Scio-Discover
    Pathway
Coverage
    Biomarker
Discovery
    Contact
us

 

Reference Customers:

  • Dr. Ghaith Bakdash, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
  • Dr. Anke Dienelt, Julius Wolff Institut, Charité, Berlin, Germany
  • Dr. Eric Eldering, Academic Medical Center, Amsterdam, The Netherlands
  • Dr. Reece Marillier, Ludwig Institute for Cancer Research Ltd, Brussels, Belgium
  • Prof. Jose L. Peiró, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, USA
 

Case studies:

Bladder Cancer

Acute Kidney Injury

 

* Antibody array is designed to target human proteins. Due to a high sequence homology of vast majority of proteins it was often successfully applied to study murine, rat and ovine models as well  [Thorenz A. et al. (2018), Peiro J. et al. (2018), Reichman H. et al. (2019), Raquel F. et al. (2020)].

** Depending on study design and sample numbers.

 

Subcategories